WHO ICTRP trial
Efficacy of adjuvant mitotane treatment in prolonging disease-free survival in…
EUCTR2007-007262-38-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-007262-38-IT |
|---|---|
| Public title | Efficacy of adjuvant mitotane treatment in prolonging disease-free survival in patients with adrenocortical cacinoma submitted to radical resection - ADIUVO |
| Scientific title | Efficacy of adjuvant mitotane treatment in prolonging disease-free survival in patients with adrenocortical cacinoma submitted to radical resection - ADIUVO |
| Primary sponsor | AZIENDA OSPEDALIERA S. LUIGI GONZAGA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;Italy |
| Conditions | PATIENTS WITH ADRENOCORTICAL CARCINOMA SUBMITTED TO RARICAL SURGERY MedDRA version: 9.1 Level: LLT Classification code 10001388 Term: Adrenocortical carcinoma |
| Interventions | Trade Name: LYSODREN Pharmaceutical Form: Tablet INN or Proposed INN: Mitotane Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 500- |
| Registration date | Mar 20, 2008 |
| Target size | 200 |
| Secondary IDs | ADIUVO |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: